Consistently, immunohistochemistry of human postmortem AD brains revealed reduction of SRRM2 and PQBP1 in the nucleus in addition to increase of pSer1068-SRRM2 in the cytoplasm (Fig. 3g). The gene discussed is SRRM2; the disease is Alzheimer disease.